ELRITERCEPT
UNII ZNC37E4KAK

Substance Identification & Data

This profile provides standardized clinical and technical data for Elritercept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZNC37E4KAK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2727114-26-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZNC37E4KAK

CAS Registry Number

2727114-26-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ELRITERCEPT

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C199201

National Cancer Institute reference terminology for clinical and research data.

INN ID

12526

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-15

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Elritercept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ELRITERCEPT

Common Names & Synonyms

1-109-ACTIVIN RECEPTOR TYPE IIA (HUMAN CONSTRUCT KER-050) FUSION PROTEIN WITH PEPTIDE LINKER (GGG) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (DE-339-LYSINE) (HUMAN .GAMMA.1-CHAIN C-TERMINAL FRAGMENT), DIMER

ELRITERCEPT [INN]

ELRITERCEPT [USAN]

ELRITERCEPT [WHO-DD]

HUMAN ACTIVIN RECEPTOR TYPE 2-A (ACTIVIN RECEPTOR TYPE IIA, ACTR-IIA) EXTRACELLULAR DOMAIN (ECD) FRAGMENT (1-109) ENGINEERED VARIANT (F15>Y, 21KD22>LE, P31>R, Y33>E, D35>E, R40>L, F43>Y, K47>R, Q58>K, I65>F, 76KKDS79>TEEN, E81>Q) FUSED VIA THE PEPTIDE LINKER 110GGG112 TO A HUMAN IMMUNOGLOBULIN G1 HEAVY CHAIN FRAGMENT C-TERMINAL FC FRAGMENT (113-338), (HOMO SAPIENS IGHG1*01; HINGE: 113-122 (EPKSC 112-113DEL); CH2: 123-232; CH3: 233-337; CHS: 338-338 (K339DEL)); DISULFIDE BRIDGED DIMER, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA